Editas Medicine (EDIT)
(Real Time Quote from BATS)
$10.89 USD
+0.28 (2.64%)
Updated Nov 30, 2023 09:36 AM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Detailed Estimates
Estimates
Exp Earnings Date | 2/28/24 |
---|---|
Current Quarter | -0.61 |
EPS Last Quarter | -0.55 |
Last EPS Surprise | 14.06% |
ABR | 2.11 |
Earnings ESP
|
2.37% |
---|---|
Current Year | -2.42 |
Next Year | -2.54 |
EPS (TTM) | -2.70 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 5.67M | 4.32M | 22.51M | 25.40M |
# of Estimates | 6 | 3 | 9 | 7 |
High Estimate | 8.90M | 7.50M | 27.00M | 50.00M |
Low Estimate | 3.00M | 2.47M | 18.07M | 9.60M |
Year ago Sales | 6.54M | 9.85M | 19.71M | 22.51M |
Year over Year Growth Est. | -13.33% | -56.11% | 14.20% | 12.85% |
Earnings Estimates
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.61 | -0.66 | -2.42 | -2.54 |
# of Estimates | 10 | 5 | 12 | 12 |
Most Recent Consensus | -0.64 | -0.72 | -2.46 | -2.99 |
High Estimate | -0.36 | -0.61 | -2.15 | -2.00 |
Low Estimate | -0.83 | -0.72 | -2.68 | -3.47 |
Year ago EPS | -0.88 | -0.71 | -3.21 | -2.42 |
Year over Year Growth Est. | 30.68% | 7.04% | 24.61% | -5.13% |
Agreement - Estimate Revisions
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 4 | 2 | 5 | 8 |
Up Last 60 Days | 4 | 2 | 5 | 8 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 3 | 2 | 6 | 3 |
Down Last 60 Days | 3 | 2 | 6 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Current | -0.61 | -0.66 | -2.42 | -2.54 |
7 Days Ago | -0.61 | -0.66 | -2.42 | -2.54 |
30 Days Ago | -0.67 | -0.67 | -2.54 | -2.64 |
60 Days Ago | -0.67 | -0.67 | -2.54 | -2.69 |
90 Days Ago | -0.69 | -0.67 | -2.55 | -2.68 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.60 | -0.66 | -2.40 | -2.55 |
Zacks Consensus Estimate | -0.61 | -0.66 | -2.42 | -2.54 |
Earnings ESP | 2.37% | 0.00% | 0.65% | -0.43% |
Surprise - Reported Earnings History
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Quarter Ending (12/2022) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.55 | -0.56 | -0.71 | -0.88 | NA |
Estimate | -0.64 | -0.76 | -0.79 | -0.84 | NA |
Difference | 0.09 | 0.20 | 0.08 | -0.04 | 0.08 |
Surprise | 14.06% | 26.32% | 10.13% | -4.76% | 11.44% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more